The global digital diabetes management market size is expected to reach around US$ 90 billion by 2030 from US$ 19.02 billion in 2021and is expected to grow at an impressive double-digit rate of 18.85% from 2022 to 2030. The major industry leaders operating in the digital diabetes management are focusing on providing innovative products and introducing advanced technologies in this market.
The study includes drivers and restraints of this market. The study provides an analysis of the global digital diabetes management market for the period 2017-2030, wherein 2022 to 2030 is the forecast period and 2021 is considered as the base year.
Report Scope of the Digital Diabetes Management Market
| Report Coverage | Details |
| Market Size by 2030 | USD 90 Billion |
| Growth Rate from 2022 to 2030 | CAGR of 18.85% |
| Largest Market | North America |
| Fastest Growing Region | Asia Pacific |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
Our Free Sample Reports Includes:
- In-depth Industry Analysis, Introduction, Overview, and COVID-19 Pandemic Outbreak.
- Impact Analysis 150+ Pages Research Report (Including latest research).
- Provide chapter-wise guidance on request 2022 Updated Regional Analysis with Graphical Representation of Trends, Size, & Share, Includes Updated List of figures and tables.
- Updated Report Includes Major Market Players with their Sales Volume, Business Strategy and Revenue Analysis by using Precedence Research methodology.
Download Free Sample Copy Here (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/sample/1783
Research Methodology
A unique research methodology has been utilized to conduct comprehensive research on the growth of the global digital diabetes management market and arrive at conclusions on the future growth prospects of the market. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the draw conclusions. Secondary sources referred to by analysts during the production of the global market report include statistics from company annual reports, SEC filings, company websites, World Bank database, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of our study on the market as a primary source.
These primary and secondary sources provided exclusive information during interviews, which serves as a validation from mattress topper industry leaders. Access to an extensive internal repository and external proprietary databases allows this report to address specific details and questions about the global digital diabetes management market with accuracy. The study also uses the top-down approach to assess the numbers for each segment and the bottom-up approach to counter-validate them. This has helped to estimates the future prospects of the global market more reliable and accurate.
Why should you invest in this report?
If you are aiming to enter the global digital diabetes management market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for digital diabetes management are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030, so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Some of the prominent players in the global digital diabetes management market include:
- Bayer AG
- Medtronic
- Roche Diagnostics
- Dexcom Inc. LifeScan Inc.
- AgaMatrix
- One Drop
- Abbott Laboratories
- Ascensia Diabetes Care
- ARKRAY Inc
- ACON Laboratories
- Insulet Corporation
- B. Braun Melsungen AG
- Tandem Diabetes Care
- Dottli
- Ypsomed Holding AG
- Becton Dickinson and Company
- Glooko Inc.
- DarioHealth
- Care innovations
Market Segmentation:
By Product
- Devices
- Smart Glucose Meters
- Continuous Glucose Monitoring (CGM) Systems
- Smart Insulin Pens
- Smart Insulin Pumps/Closed-loop Pumps & Smart Insulin Patches
- Application
- Diabetes & Blood Glucose Tracking Apps
- Obesity & Diet Management Apps
- Data Management Software & Platforms
- Services
- Apps
- Software
By Device Type
- Handheld Devices
- Wearable Devices
By Patient Type
- Type 1
- Type 2
By App
- Digital Diabetes Management Apps
- Weight & Diet Management Apps
By End-Use
- Hospitals
- Home Settings
- Diagnostic Centers & Clinics
Regional Analysis:
The geographical analysis of the global digital diabetes management market has been done for North America, Europe, Asia-Pacific, and the Rest of the World.
The North American Market is again segmented into the US, Canada, and Mexico. Coming to the European Market, it can be segmented further into the UK, Germany, France, Italy, Spain, and the rest. Coming to the Asia-Pacific, the global digital diabetes management Market is segmented into China, India, Japan, and Rest of Asia Pacific. Among others, the market is segmented into the Middle East and Africa, (GCC, North Africa, South Africa and Rest of the Middle East & Africa).
Key Questions Answered by the Report:
- What will be the size of the global digital diabetes management market in 2030?
- What is the expected CAGR for the digital diabetes management market between 2021 and 2030?
- Which are the top players active in this global market?
- What are the key drivers of this global market?
- How will the market situation change in the coming years?
- Which region held the highest market share in this global market?
- What are the common business tactics adopted by players?
- What is the growth outlook of the global digital diabetes management market?
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Digital Diabetes Management Market
5.1. COVID-19 Landscape: Digital Diabetes Management Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Digital Diabetes Management Market, By Product
8.1. Digital Diabetes Management Market, by Product, 2022-2030
8.1.1. Devices
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Application
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Data Management Software & Platforms
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Services
8.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Digital Diabetes Management Market, By Device Type
9.1. Digital Diabetes Management Market, by Device Type, 2022-2030
9.1.1. Handheld Devices
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Wearable Devices
9.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Digital Diabetes Management Market, By Patient Type
10.1. Digital Diabetes Management Market, by Patient Type, 2022-2030
10.1.1. Type 1
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Type 2
10.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Digital Diabetes Management Market, By App
11.1. Digital Diabetes Management Market, by App, 2022-2030
11.1.1. Digital Diabetes Management Apps
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Weight & Diet Management Apps
11.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Digital Diabetes Management Market, By End-Use
12.1. Digital Diabetes Management Market, by End-Use, 2022-2030
12.1.1. Hospitals
12.1.1.1. Market Revenue and Forecast (2017-2030)
12.1.2. Home Settings
12.1.2.1. Market Revenue and Forecast (2017-2030)
12.1.3. Diagnostic Centers& Clinics
12.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 13. Global Digital Diabetes Management Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Product (2017-2030)
13.1.2. Market Revenue and Forecast, by Device Type (2017-2030)
13.1.3. Market Revenue and Forecast, by Patient Type (2017-2030)
13.1.4. Market Revenue and Forecast, by App (2017-2030)
13.1.5. Market Revenue and Forecast, by End-Use (2017-2030)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Product (2017-2030)
13.1.6.2. Market Revenue and Forecast, by Device Type (2017-2030)
13.1.6.3. Market Revenue and Forecast, by Patient Type (2017-2030)
13.1.6.4. Market Revenue and Forecast, by App (2017-2030)
13.1.7. Market Revenue and Forecast, by End-Use (2017-2030)
13.1.8. Rest of North America
13.1.8.1. Market Revenue and Forecast, by Product (2017-2030)
13.1.8.2. Market Revenue and Forecast, by Device Type (2017-2030)
13.1.8.3. Market Revenue and Forecast, by Patient Type (2017-2030)
13.1.8.4. Market Revenue and Forecast, by App (2017-2030)
13.1.8.5. Market Revenue and Forecast, by End-Use (2017-2030)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Product (2017-2030)
13.2.2. Market Revenue and Forecast, by Device Type (2017-2030)
13.2.3. Market Revenue and Forecast, by Patient Type (2017-2030)
13.2.4. Market Revenue and Forecast, by App (2017-2030)
13.2.5. Market Revenue and Forecast, by End-Use (2017-2030)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Product (2017-2030)
13.2.6.2. Market Revenue and Forecast, by Device Type (2017-2030)
13.2.6.3. Market Revenue and Forecast, by Patient Type (2017-2030)
13.2.7. Market Revenue and Forecast, by App (2017-2030)
13.2.8. Market Revenue and Forecast, by End-Use (2017-2030)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Product (2017-2030)
13.2.9.2. Market Revenue and Forecast, by Device Type (2017-2030)
13.2.9.3. Market Revenue and Forecast, by Patient Type (2017-2030)
13.2.10. Market Revenue and Forecast, by App (2017-2030)
13.2.11. Market Revenue and Forecast, by End-Use (2017-2030)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Product (2017-2030)
13.2.12.2. Market Revenue and Forecast, by Device Type (2017-2030)
13.2.12.3. Market Revenue and Forecast, by Patient Type (2017-2030)
13.2.12.4. Market Revenue and Forecast, by App (2017-2030)
13.2.13. Market Revenue and Forecast, by End-Use (2017-2030)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Product (2017-2030)
13.2.14.2. Market Revenue and Forecast, by Device Type (2017-2030)
13.2.14.3. Market Revenue and Forecast, by Patient Type (2017-2030)
13.2.14.4. Market Revenue and Forecast, by App (2017-2030)
13.2.15. Market Revenue and Forecast, by End-Use (2017-2030)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Product (2017-2030)
13.3.2. Market Revenue and Forecast, by Device Type (2017-2030)
13.3.3. Market Revenue and Forecast, by Patient Type (2017-2030)
13.3.4. Market Revenue and Forecast, by App (2017-2030)
13.3.5. Market Revenue and Forecast, by End-Use (2017-2030)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Product (2017-2030)
13.3.6.2. Market Revenue and Forecast, by Device Type (2017-2030)
13.3.6.3. Market Revenue and Forecast, by Patient Type (2017-2030)
13.3.6.4. Market Revenue and Forecast, by App (2017-2030)
13.3.7. Market Revenue and Forecast, by End-Use (2017-2030)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Product (2017-2030)
13.3.8.2. Market Revenue and Forecast, by Device Type (2017-2030)
13.3.8.3. Market Revenue and Forecast, by Patient Type (2017-2030)
13.3.8.4. Market Revenue and Forecast, by App (2017-2030)
13.3.9. Market Revenue and Forecast, by End-Use (2017-2030)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Product (2017-2030)
13.3.10.2. Market Revenue and Forecast, by Device Type (2017-2030)
13.3.10.3. Market Revenue and Forecast, by Patient Type (2017-2030)
13.3.10.4. Market Revenue and Forecast, by App (2017-2030)
13.3.10.5. Market Revenue and Forecast, by End-Use (2017-2030)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Product (2017-2030)
13.3.11.2. Market Revenue and Forecast, by Device Type (2017-2030)
13.3.11.3. Market Revenue and Forecast, by Patient Type (2017-2030)
13.3.11.4. Market Revenue and Forecast, by App (2017-2030)
13.3.11.5. Market Revenue and Forecast, by End-Use (2017-2030)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Product (2017-2030)
13.4.2. Market Revenue and Forecast, by Device Type (2017-2030)
13.4.3. Market Revenue and Forecast, by Patient Type (2017-2030)
13.4.4. Market Revenue and Forecast, by App (2017-2030)
13.4.5. Market Revenue and Forecast, by End-Use (2017-2030)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Product (2017-2030)
13.4.6.2. Market Revenue and Forecast, by Device Type (2017-2030)
13.4.6.3. Market Revenue and Forecast, by Patient Type (2017-2030)
13.4.6.4. Market Revenue and Forecast, by App (2017-2030)
13.4.7. Market Revenue and Forecast, by End-Use (2017-2030)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Product (2017-2030)
13.4.8.2. Market Revenue and Forecast, by Device Type (2017-2030)
13.4.8.3. Market Revenue and Forecast, by Patient Type (2017-2030)
13.4.8.4. Market Revenue and Forecast, by App (2017-2030)
13.4.9. Market Revenue and Forecast, by End-Use (2017-2030)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Product (2017-2030)
13.4.10.2. Market Revenue and Forecast, by Device Type (2017-2030)
13.4.10.3. Market Revenue and Forecast, by Patient Type (2017-2030)
13.4.10.4. Market Revenue and Forecast, by App (2017-2030)
13.4.10.5. Market Revenue and Forecast, by End-Use (2017-2030)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Product (2017-2030)
13.4.11.2. Market Revenue and Forecast, by Device Type (2017-2030)
13.4.11.3. Market Revenue and Forecast, by Patient Type (2017-2030)
13.4.11.4. Market Revenue and Forecast, by App (2017-2030)
13.4.11.5. Market Revenue and Forecast, by End-Use (2017-2030)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Product (2017-2030)
13.5.2. Market Revenue and Forecast, by Device Type (2017-2030)
13.5.3. Market Revenue and Forecast, by Patient Type (2017-2030)
13.5.4. Market Revenue and Forecast, by App (2017-2030)
13.5.5. Market Revenue and Forecast, by End-Use (2017-2030)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Product (2017-2030)
13.5.6.2. Market Revenue and Forecast, by Device Type (2017-2030)
13.5.6.3. Market Revenue and Forecast, by Patient Type (2017-2030)
13.5.6.4. Market Revenue and Forecast, by App (2017-2030)
13.5.7. Market Revenue and Forecast, by End-Use (2017-2030)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Product (2017-2030)
13.5.8.2. Market Revenue and Forecast, by Device Type (2017-2030)
13.5.8.3. Market Revenue and Forecast, by Patient Type (2017-2030)
13.5.8.4. Market Revenue and Forecast, by App (2017-2030)
13.5.8.5. Market Revenue and Forecast, by End-Use (2017-2030)
Chapter 14. Company Profiles
14.1. Bayer AG
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Medtronic
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Roche Diagnostics
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Dexcom Inc. LifeScan Inc.
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. AgaMatrix
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. One Drop
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Abbott Laboratories
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Ascensia Diabetes Care
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. ARKRAY Inc
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. ACON Laboratories
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
0 Comments